Jane Street Group, LLC Immunity Bio, Inc. Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$3.32 - $6.7 $208,828 - $421,430	62,900 New	62,900 $233,000
Q1 2022 May 17, 2022	BUY	$5.05 - $7.53 $176,245 - $262,797	34,900 Added 59.56%	93,500 $525,000
Q4 2021 Feb 15, 2022	BUY	$5.67 - $10.18 $120,771 - $216,834	21,300 Added 57.1%	58,600 $356,000
Q3 2021 Nov 16, 2021	SELL	$9.17 - $14.24 $296,191 - $459,952	-32,300 Reduced 46.41%	37,300 $363,000
Q2 2021 Aug 16, 2021	SELL	$13.41 - $22.4 $1.52 Million - $2.54 Million	-113,600 Reduced 62.01%	69,600 $994,000
Q1 2021 May 18, 2021	BUY	$12.83 - $42.25 $2.35 Million - $7.74 Million	183,200 New	183,200 $4.35 Million

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.